More tools:Markets·Screener·Research·Chat

West Pharmaceutical Services, Inc. (WST) Financial Statements

West Pharmaceutical Services, Inc.
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S5XK22
XNYS · usd
351.37▼ 0.76 (-0.22%)
As of 2026-08-11
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$3.3B
Net Income (TTM)$564.9M
EBITDA
Diluted EPS (TTM)
EBITDA Margin25.9%
Net Debt
Trading Information
Previous Close352.13
Day's Range348.12 – 354.05
52-Week Range223.83 – 386.00
Volume388.0K
Avg Volume749.5K
Share Statistics
Shares Outstanding70.6M
Employees10.8K
ExchangeXNYS
Listed1973-01-02
Loading Income Statement…
Key questions about West Pharmaceutical Services, Inc. (WST)
What is West Pharmaceutical Services, Inc.'s Market Cap?
West Pharmaceutical Services, Inc.'s Market Cap is $24.8B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Enterprise Value?
West Pharmaceutical Services, Inc.'s Enterprise Value is $24.5B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Trailing P/E?
West Pharmaceutical Services, Inc.'s Trailing P/E is 43.9×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Price / Sales?
West Pharmaceutical Services, Inc.'s Price / Sales is 7.5×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EV / Revenue?
West Pharmaceutical Services, Inc.'s EV / Revenue is 7.4×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EV / EBITDA?
West Pharmaceutical Services, Inc.'s EV / EBITDA is 28.4×, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Revenue (TTM)?
West Pharmaceutical Services, Inc.'s Revenue (TTM) is $3.3B, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Net Income (TTM)?
West Pharmaceutical Services, Inc.'s Net Income (TTM) is $564.9M, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s EBITDA?
West Pharmaceutical Services, Inc.'s EBITDA is $861.8M, based on as-reported figures from SEC (XBRL) filings.
What is West Pharmaceutical Services, Inc.'s Diluted EPS (TTM)?
West Pharmaceutical Services, Inc.'s Diluted EPS (TTM) is 8.00, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net sales
YoY growth+13.8%+21.0%+7.5%+7.7%
Cost of goods and services sold
Gross profit
% of revenue37.7%35.1%37.8%36.6%
Research and development
Selling, general and administrative expenses
Operating profit
% of revenue20.5%21.0%19.5%20.8%
Interest expense, net
Interest income
Other nonoperating expense (income)
Income before income taxes and equity in net income of affiliated companies
Basic (in dollars per share)—
Diluted (in dollars per share)—